Schedule 13D ownership disclosure

Supernus Pharmaceuticals Inc

Security class unavailable · CUSIP: 868459108

Event date: 2014-08-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000905718-14-000554
Form type
SC 13D/A
Filer
Abingworth Management LTD
CIK
CIK 1291892
Filed
Aug 25, 2014
Reporting period
Aug 14, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub